LanZhou Foci Pharmaceutical Co.,Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 860.51 million compared to CNY 698.41 million a year ago. Revenue was CNY 860.51 million compared to CNY 698.41 million a year ago.

Net income was CNY 59.12 million compared to CNY 52.88 million a year ago. Basic earnings per share from continuing operations was CNY 0.1158 compared to CNY 0.1035 a year ago. Diluted earnings per share from continuing operations was CNY 0.1158 compared to CNY 0.1035 a year ago.